pristane has been researched along with Disease Models, Animal in 160 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (1.88) | 18.7374 |
1990's | 16 (10.00) | 18.2507 |
2000's | 34 (21.25) | 29.6817 |
2010's | 73 (45.63) | 24.3611 |
2020's | 34 (21.25) | 2.80 |
Authors | Studies |
---|---|
Dou, H; Hou, Y; Kong, W; Li, D; Li, J; Liang, J; Lu, L; Pan, Y; Wang, J; Wang, T; Xia, X | 1 |
Boneva, GV; Bradyanova, SL; Chakarova, IV; Delimitreva, SM; Hadzhinesheva, VP; Kolarov, AI; Markova, MD; Mladenov, NJ; Nikolova, VP; Tchorbanov, AI; Zhivkova, RS | 1 |
Guo, Y; He, Z; Hu, L; Li, F; Li, Q; Long, D; Long, H; Lu, L; Lu, Q; Wu, H; Yang, M; Zhao, M; Zhao, Z | 1 |
Takeuchi, O; Wakabayashi, A; Yoshinaga, M | 1 |
Akaveka, L; Contreras, J; Forbess, LJ; Ishimori, M; Jefferies, CA; Laguna, DE; Montano, EN; Moore, RE; Santos, GL; Stripp, BR; Tumurkhuu, G; Venuturupalli, S; Wallace, DJ; Wang, Y | 1 |
Bartikoski, BJ; Busatto, A; de Souza Silva, JM; do Espírito Santo, RC; Dos Santos, M; Freitas, EC; Monticielo, OA; Xavier, RM | 1 |
Dai, X; Fang, Y; Huang, Y; Ma, K; Qin, R; Zhou, J | 1 |
Chantaravisoot, N; Kalpongnukul, N; Kumpunya, S; Leelahavanichkul, A; Pisitkun, P; Pisitkun, T; Thim-Uam, A; Thumarat, C | 1 |
Ding, XH; Jin, YB; Qian, SH; Xiang, ST; Zhang, JJ; Zhang, MG | 1 |
Clark, EA; Draves, KE; Elkon, KB; Giltiay, NV; Giordano, D; Kuley, R | 1 |
Chen, W; He, X; Jin, S; Liu, J; Liu, W; Luo, Z; Wang, P; Wang, X; Yang, L; Zhang, T; Zhang, Y; Zhang, Z | 1 |
Fu, D; Senouthai, S; Wang, J; You, Y | 1 |
Bañuelos-Pineda, J; Corona-Meraz, FI; Floresvillar-Mosqueda, JF; Gutiérrez-Mercado, YK; Luciano-Jaramillo, J; Martín-Márquez, BT; Martínez-García, EA; Navarro-Hernández, RE; Pizano-Martínez, O; Sandoval-García, F; Vázquez-Del Mercado, M | 1 |
Alarcón-de-la-Lastra, C; Aparicio-Soto, M; Castejon, ML; Fernández-Bolaños, JG; Martín-LaCave, I; Montoya, T; Sánchez-Hidalgo, M | 1 |
Bhatnagar, A; Pannu, N | 3 |
Gulko, PS; Laragione, T; Ouellette, AJ; Punj, V; Schaal, JB; Selsted, ME; Subramanian, A; Tongaonkar, P; Tran, DQ; Trinh, KK | 1 |
Bai, C; Chen, H; He, X; Huang, Z; Lei, Y; Liu, Z; Su, Q; Tian, X; Wei, F; Yin, M; Yu, B; Zhao, Q; Zhou, X | 1 |
Jing, C; Song, Z; Yin, Y; Zhang, X; Zheng, Y | 1 |
Chatthanathon, P; Hiengrach, P; Issara-Amphorn, J; Jaroonwitchawan, T; Leelahavanichkul, A; Palaga, T; Pisitkun, P; Somboonna, N; Surawut, S; Thim-Uam, A; Wilantho, A | 1 |
Liu, A; Xiang, L; Xu, G | 1 |
Abdelhamid, L; Cabana-Puig, X; Cecere, TE; Lee, J; LeRoith, T; Li, S; Li, Y; Luo, XM; Reilly, CM; Ross, AC; Sun, S; Swartwout, B; Wang, H; Werre, SR | 1 |
Dan, Y; Duan, D; Hua, W; Ouyang, L; Shao, Z | 1 |
Asano, R; Inagaki, T; Ishibashi, T; Ishibashi-Ueda, H; Kumanogoh, A; Manabe, Y; Masaki, T; Mori, H; Nakaoka, Y; Narazaki, M; Ohta-Ogo, K; Okazawa, M | 1 |
Jin, R; Liu, C; Long, Y; Lu, S; Song, Y; Sun, X; Sun, XH; Yu, S; Zhang, Y | 1 |
Agliano, F; Karlinsey, KS; Ménoret, A; Ragazzi, M; Vella, AT | 1 |
Arditi, M; Blanco, LP; Chen, S; Crother, TR; De Los Santos, G; Ercan Laguna, D; Ishimori, M; Jefferies, CA; Kaplan, MJ; Lane, M; Markman, JL; Montano, EN; Shimada, K; Tumurkhuu, G; Wallace, DJ; Yamashita, M; Yu, JM | 1 |
Awo, EA; Burgin, M; Guo, Q; Lucas, AR; Schutz, LN; Yaron, JR; Zhang, L | 1 |
Jones, KE; Kalusche, WJ; McClung, DM; Ryan, MJ; Taylor, EB | 1 |
Barnes, BJ; Chen, M; Clapp, WL; Cui, M; Lu, A; Meng, G; Niu, J; Wu, S | 1 |
Gao, J; Liu, H; Liu, X; Song, X; Tang, K | 1 |
Lee, BH; Shetti, D | 1 |
Cao, H; Gu, Y; Jiao, X; Li, G; Li, N; Li, X; Shao, F; Shi, M; Sun, K; Yan, L; Yang, Z; Zhou, P | 1 |
Dai, X; Fang, X; Jin, L; Li, M; Li, X; Tao, J; Wang, Y; Xia, Y | 1 |
Feng, J; Fu, W; Han, P; Hou, J; Li, J; Li, Z; Liu, C; Liu, F; Liu, Y; Ma, Y; Mu, R; Niu, J; Xu, D; Yang, G | 1 |
Chaimovitz, C; Douvdevani, A; Haviv, YS; Mazar, J; Naamani, O; Riff, R | 1 |
Chen, M; Feng, Y; Jang, A; Sharp, R; Wang, J; Wang, JM | 1 |
Cai, L; Qiu, Y; Shen, H; Shi, Q; Wang, J; Wang, Z; Zhu, Y | 1 |
Hou, W; Jiang, C; Lu, S; Meng, L; Wang, B; Xu, K; Xu, P; Zhou, Y; Zhu, W | 1 |
Han, S; Li, H; Reeves, WH; Shumyak, S; Wu, J; Yang, LJ; Zhuang, H | 1 |
de Oliveira, MS; Freitas, EC; Monticielo, OA | 1 |
Dronjak, S; Hoffmann, M; Jankovic, M; Jeremic, I; Jovanovic, P; Spasojevic, N; Stefanovic, B | 1 |
Bonomini, F; Dos Santos, M; Favero, G; Rezzani, R; Rodella, LF; Stacchiotti, A; Veronese, FV | 1 |
Cai, Y; Hou, W; Jiang, C; Lu, S; Meng, L; Wang, B; Wang, L; Zhao, P; Zhou, Y; Zhu, W | 1 |
Chen, B; Shi, J; Wang, S; Yang, S; Zhao, X | 1 |
Athanassakis, I; Bakela, K; Batsou, P; Dimakopoulou, M; Manidakis, N | 1 |
Han, S; Li, H; Reeves, WH; Shumyak, S; Wu, J; Xie, C; Yang, LJ; Zhuang, H | 1 |
Bona, SR; Bonomini, F; Dos Santos, M; Favero, G; Marroni, NP; Montanari, CC; Poletti, PT; Rezzani, R; Stacchiotti, A; Veronese, FV | 1 |
Hiramatsu, S; Hirashima, M; Katsuyama, E; Katsuyama, T; Kawabata, T; Matsumoto, Y; Niki, T; Sada, KE; Teshigawara, S; Wada, J; Watanabe, H; Watanabe, KS; Zeggar, S | 1 |
Huang, B; Jiang, J; Liu, Y; Luo, B; Wang, Z; Zhang, Z; Zhu, W | 1 |
Agdana, HM; Handono, K; Hasanah, D; Hermawan, HO; Kalim, H; Kawuningan, KB; Nur'aini, N; Pratama, MZ; Sari, DK | 1 |
Esmaeili, SA; Khorasani, S; Mahmoudi, M; Mardani, F; Rastin, M; Tabasi, N | 1 |
Björkbacka, H; Contreras, J; Cunningham, K; Fernando, T; Forbess, L; Gabhann, JN; Ishimori, M; Jefferies, CA; Jin, M; Kearns, G; Kong, W; Kornfeld, H; McCarthy, EM; Molloy, ES; Montano, EN; Murphy, CC; Seo, JJ; Smith, S; Venuturupalli, S; Wallace, D; Weisman, MH; Widaa, A; Wu, PW | 1 |
Li, YS; Xu, SP | 1 |
Esmaeili, SA; Kalantari, MR; Khorasani, S; Lavi Arab, F; Mahmoudi, M; Mardani, F; Rastin, M; Tabasi, N | 1 |
Chindamporn, A; Leelahavanichkul, A; Makjaroen, J; Palaga, T; Pisitkun, P; Surawut, S; Thim-Uam, A; Wongphoom, J | 1 |
Albuquerque, LL; Borrego, A; Cabrera, WHK; De Franco, M; Ibañez, OM; Jensen, JR; Katz, ISS; Ribeiro, OG; Rossato, C; Spadafora-Ferreira, M; Starobinas, N | 1 |
André Monticielo, O; Cavalheiro do Espírito Santo, R; Correa Freitas, E; da Costa Gonçalves, F; da Rosa, TH; de Oliveira, FH; de Oliveira, MS; de Souza Silva, JM; Evelyn Karnopp, T; Guilherme Schaefer, P | 1 |
Bai, C; Chen, H; He, X; Huang, Z; Liang, J; Liu, Z; Su, Q; Tian, X; Wei, F; Yin, M; Yu, B; Zhao, Q; Zhou, X | 1 |
Chevalier, N; Daniel, C; Eichhorst, A; Nimmerjahn, F; Rzepka, R; Sehnert, B; Voll, RE | 1 |
Bandur, T; Blüml, S; Leiss, H; Niederreiter, B; Schwarzecker, B; Smolen, JS; Steiner, G; Stummvoll, GH; Ulrich, W | 1 |
Bonegio, R; Bossaller, L; Busto, P; Caffrey, DR; Chiang, PI; Fitzgerald, KA; Latz, E; Li, QZ; Marshak-Rothstein, A; Mohan, C; Rathinam, VA; Wespiser, AR | 1 |
Hodgin, JB; Kahlenberg, JM; Kaplan, MJ; Reed, TJ; Tsuji, NM; Yalavarthi, S; Zhao, W | 1 |
Akare, S; Bender, AT; Cao, Q; Ding, Y; Genest, M; Ishizaka, ST; Mackey, MF; Oestreicher, J; Wu, Y | 1 |
Morel, L; Reeves, WH; Xu, Y; Zeumer, L | 1 |
Holdsworth, SR; Khouri, MB; Kitching, AR; Odobasic, D; Steinmetz, OM; Summers, SA; Yang, Y | 1 |
Botte, DA; de Mello, SB; Malheiros, DM; Noronha, IL; Peixoto, TV | 1 |
Goilav, B; Herlitz, L; Pawar, RD; Putterman, C; Reeves, WH; Xia, Y; Zhuang, H | 1 |
Han, S; Liu, C; Massini, J; Mathews, CE; Reeves, WH; Wang, H; Xu, Y; Yang, L; Zhuang, H | 1 |
Beeton, C; Gulko, PS; Horrigan, FT; Hu, X; Huq, R; Khan, FS; Laragione, T; Sun, L; Tajhya, RB; Tanner, MR | 1 |
Balazs, M; Caplazi, P; DeForge, L; Lee, WP; Lin, W; Lin, Z; Martin, F; McVay, S; Nguyen, A; Seshasayee, D; Sun, Y; Suto, E; Zarrin, AA | 1 |
Agerberth, B; Amann, K; Barron, AE; Borràs, ÈB; Hahn, J; Hoffmann, MH; Hueber, AJ; Ipseiz, N; Kienhöfer, D; Lang, SC; Reinwald, C; Schett, G; Schubert, I; Sjöwall, C | 1 |
Bäcklund, J; Dobritzsch, D; Haag, S; Holmdahl, R; Mason, DE; Peters, EC; Thordardottir, S; Tuncel, J; Yau, AC | 1 |
Dickerhof, N; Holdsworth, SR; Kettle, AJ; Kitching, AR; Muljadi, RC; O'Sullivan, KM; Odobasic, D; Summers, SA | 1 |
Huang, L; Kong, Y; Qiu, YH; Shi, Q; Sun, J; Wang, J | 1 |
Cascalho, M; Clark, KL; Kahlenberg, JM; Morse, MD | 1 |
Farfán-Morales, JE; García-Vázquez, FJ; Jiménez-Zamudio, LA; Sánchez-González, B | 1 |
Brohawn, P; Harley, JB; Higgs, BW; Huang, X; Jallal, B; Jia, Q; Liu, Z; Meng, Y; Qu, B; Shen, N; Tang, Y; Wang, Y; Xiao, C; Yao, Y; Zhou, S | 1 |
Andrade, LR; Bernardes, ES; Brand, C; Chammas, R; da Costa, TP; de Oliveira, FL; El-Cheikh, MC; Machado, CM | 1 |
Ma, H; Wan, S; Xia, CQ | 1 |
Choi, HS; Han, S; Lee, P; Li, Y; Reeves, WH; Sun, Y; Vidal, O; Wilson, JC; Xu, Y; Yang, LJ; Zhuang, H | 1 |
Botto, M; Carlucci, F; Cook, HT; Donatien, P; Ishaque, A; Ling, GS; Sandison, A; Szajna, M | 1 |
Bender, AT; Caldwell, R; Chen, YY; Fu, K; Genest, M; Grenningloh, R; Head, J; Koehler, U; Liu-Bujalski, L; Morandi, F; Okitsu, SL; Pereira, A; Samy, E; Tian, H; Wu, Y; Xu, D | 1 |
Cui, B; Gao, X; Jiao, Y; Liu, X; Xu, J; Zhao, Y | 1 |
Bäcklund, J; Fischer, A; Gulko, PS; Haag, S; Haase, C; Hoffmann, MH; Holmdahl, R; Hultqvist, M; Lange, F; Leichsenring, A; Lu, S; Nandakumar, KS; Olofsson, P; Steiner, G; Tuncel, J; Weidner, D; Yau, AC | 1 |
Chan, A; Han, S; Hoffmann, MH; Kienhöfer, D; Lee, P; Li, Y; Meyerholz, R; Reeves, WH; Rosadzinski, K; Rosner, D; Segal, M; Shumyak, S; Sobel, E; Xu, Y; Yang, LJ; Zhuang, H | 1 |
Bonegio, RG; Bossaller, L; Busto, P; Chiang, PI; Christ, A; Latz, E; Marshak-Rothstein, A; Mishra, N; Nündel, K; Pang, C; Pelka, K; Schmidt, RE | 1 |
Eitzman, DT; Guo, C; Hodgin, JB; Kleiman, K; Knight, JS; Wang, H; Wang, J | 1 |
Han, S; Reeves, WH; Shumyak, S; Yang, LJ; Zhuang, H | 1 |
He, J; Li, ZA; Liu, JF; Pan, XH; Pang, RQ; Ruan, GP; Yang, JY; Yao, X | 1 |
La Cava, A; Liu, A; Lourenço, EV; Matarese, G | 1 |
Allaire, N; Bajko, J; Browning, JL; Chou, WC; Czerkowicz, JM; Dunstan, RW; Fu, K; Gardet, A; Kerns, HM; Lafyatis, R; Legault, HM; Lukashev, M; Rabah, D; Ranger, AM; Reynolds, TL; Ryan, S; Velez, DB; Viney, JL | 1 |
Afaneh, A; Chatha, A; Han, S; Khaybullin, R; Lee, PY; Lu, L; Moldawer, L; Nacionales, D; Qi, X; Reeves, WH; Shumyak, S; Xie, C; Yang, LJ; Zhang, Y; Zhuang, H | 1 |
Bradyanova, S; Chausheva, S; Chipinski, P; Herbáth, M; Kyurkchiev, D; Mihaylova, N; Prechl, J; Tchorbanov, AI | 1 |
Gu, L; Li, X; Shen, J; Yang, L; Zhang, D | 1 |
Jiang, C; Lu, S; Meng, L; Shahzad, M; Yang, X; Zhu, W | 1 |
Lee, PY; Lu, L; Reeves, WH; Satoh, M; Weinstein, JS | 1 |
Fujimoto, M; Haas, KM; Ishiura, N; Matsushita, T; Nakashima, H; Okochi, H; Tedder, TF; Watanabe, R | 1 |
He, X; Holmdahl, R; Hou, W; Jiang, C; Lu, S; Meng, L; Zheng, F; Zhu, W | 1 |
Cain, D; Chen, H; Guan, Z; Kelsoe, G; Liao, D; McLeod, I; Raetz, C; Ueda, Y | 1 |
Si, JF; Wei, W; Yuan, DP; Zhou, LL | 1 |
Akira, S; Hoi, A; Holdsworth, SR; Kitching, AR; O'Sullivan, KM; Odobasic, D; Ooi, JD; Steinmetz, OM; Summers, SA | 1 |
Chen, XJ; Ding, J; Li, HW; Li, JZ; Merim, B; Shen, H; Wang, SJ; Wang, Y; Zhang, Y | 1 |
Du, H; He, X; Holmdahl, R; Hou, W; Jiang, C; Lu, S; Meng, L; Xu, P; Zhu, W | 1 |
Batteux, F; Brézin, A; Chéreau, C; Daudin, JB; Espy, C; Goulvestre, C; Kavian, N; Monnet, D; Nicco, C; Omri, S; Wang, A; Weill, B | 1 |
Bhatnagar, A; Das, P; Minhas, U; Minz, R | 1 |
Han, S; Lee, PY; Li, SW; Li, Y; Liu, C; Mathews, CE; Moldawer, LL; Nacionales, DC; Reeves, WH; Satoh, M; Weinstein, J; Xu, Y; Yang, LJ; Zhuang, H | 1 |
Andersson, EL; Hernell, O; Lindquist, S; Lundberg, L | 1 |
Cannon, GW; Dobbins, DE; Dracheva, SV; Furuya, T; Griffiths, MM; Gulko, PS; Hashiramoto, A; Joe, B; Remmers, EF; Salstrom, JL; Wang, J; Wilder, RL | 1 |
Cerundolo, V; Gadola, SD; Hong, S; Joyce, S; Kakumanu, SR; Mizutani, A; Park, JJ; Reeves, WH; Satoh, M; Singh, AK; Singh, RR; Stanic, AK; Van Kaer, L; Wilson, MT; Yang, JQ | 1 |
Holmberg, J; Holmdahl, R; Lu, S; Olofsson, P; Pettersson, U; Song, T; Wernhoff, P | 1 |
Akaogi, J; Behney, KM; Hirakata, M; Kuroda, Y; Mizutani, A; Nacionales, DC; Ono, N; Reeves, WH; Satoh, M; Yoshida, H | 1 |
Holmberg, J; Holmdahl, R; Olofsson, P; Wernhoff, P | 1 |
Holmberg, J; Holmdahl, R; Ibrahim, S; Koczan, D; Olofsson, P; Thiesen, HJ; Wester, L | 1 |
Akaogi, J; Kuroda, Y; Nacionales, DC; Reeves, WH; Satoh, M; Yamada, H | 1 |
Akaogi, J; Kuroda, Y; Nacionales, DC; Reeves, WH; Satoh, M | 1 |
Bush, K; Life, P; Morgan, R; Patten, C; Rioja, I; Trill, J; Wooley, P | 1 |
Bigazzi, PE | 1 |
Akaogi, J; Hirakata, M; Kuroda, Y; Mizutani, A; Nacionales, DC; Ono, N; Reeves, WH; Satoh, M; Shaheen, VM; Yamasaki, Y; Yoshida, H | 1 |
Joyce, S; Parekh, VV; Singh, AK; Singh, RR; Van Kaer, L; Wang, CR; Wei, J; Yang, JQ | 1 |
Ghetie, V; Pop, LM; Zhou, J | 1 |
Holmberg, J; Holmdahl, R; Lu, S; Olofsson, P; Tuncel, J; Yamada, H | 1 |
Holmdahl, R | 1 |
Borrego, A; Cabrera, WH; De Franco, M; Ibañez, OC; Jensen, JR; Peters, LC; Ribeiro, OG; Siqueira, M; Starobinas, N | 1 |
Al-Saleem, T; Jin, F; Joshi, I; Smith, MR | 1 |
Cui, GM; Kan, B; Liu, G; Liu, W; Mao, YQ; Wei, YQ | 1 |
Chae, BS; Park, JS; Shin, TY | 1 |
Baker, N; Borrego, A; Cabrera, WH; De Franco, M; Ibañez, OM; Jensen, JR; Peters, LC; Ribeiro, OG; Starobinas, N | 1 |
Chae, BS; Shin, TY | 1 |
Chowdhary, VR; David, CS; Grande, JP; Luthra, HS | 1 |
Kelly-Scumpia, KM; Lee, PY; Lyons, R; Nacionales, DC; Reeves, WH; Satoh, M; Sobel, E; Weinstein, JS | 1 |
Hoffmann, MH; Holmdahl, R; Pinol-Roma, S; Schett, G; Serre, G; Skriner, K; Smolen, JS; Steiner, G; Tohidast-Akrad, M; Tuncel, J; Türk, B | 1 |
Caricchio, R; Frisoni, L; Kang, SA; Madaio, M; McPhie, L; Monestier, M; Satoh, M | 1 |
Akira, S; Anders, HJ; Krug, A; Pawar, RD; Reindl, W; Savarese, E; Steinberg, C | 1 |
Chae, BS; Eun, JS; Kim, DK; Leem, JY; Shin, TY; Yang, JH | 1 |
Kanwar, YS; Kumar, A; Reeves, WH; Satoh, M | 1 |
Osmond, DG; Potter, M; Rico-Vargas, SA | 1 |
Alexander, P; Davies, DE; Farmer, S; Senior, PV; Warnes, SL; White, J | 1 |
Hinson, RM; Shacter, E; Williams, JA | 1 |
Brun, JG; Holmdahl, R; Jonsson, R; Sahlstrand, P; Saxne, T; Vingsbo, C | 1 |
Pattengale, PK | 1 |
Beech, JT; Thompson, SJ | 1 |
Hamilton, KJ; Reeves, WH; Richards, HB; Satoh, M; Swartz, J | 1 |
Gudenkauf, L; McDonald, AH; Sanger, JR; Schneider, M; Weir, K | 1 |
Holmdahl, R; Lu, S | 1 |
Joe, B; Wilder, RL | 1 |
Jennette, JC; Reeves, WH; Richards, HB; Satoh, M; Shaheen, VM; Shaw, M; Yoshida, H | 1 |
Reap, EA; Reeves, WH; Richards, HB; Satoh, M; Shaw, M; Yoshida, H | 1 |
Domján, G; Falus, A; Gadó, K; Pálóczi, K; Silva, S | 1 |
Buckton, J; Life, PF; Papworth, J; Plater-Zyberk, C; Spaull, J; Thompson, S; Zanders, E | 1 |
Akerström, B; Falkenberg, C; Holmdahl, R; Larsson, A; Nordquist, N; Olofsson, P; Pettersson, U; Vingsbo-Lundberg, C | 1 |
Asosingh, K; Radl, J; Van Camp, B; Van Riet, I; Vanderkerken, K | 1 |
Bhoola, KD; Elson, CJ; Thompson, SJ; Westacott, CI | 1 |
Elson, CJ; Hitsumoto, Y; Rook, GA; Thompson, SJ; Zhang, YW | 1 |
Butcher, PD; Elson, CJ; Patel, VK; Rook, GA; Stanford, J; Thompson, SJ; van der Zee, R | 1 |
Chapdelaine, JM; Whalen, JD; Wooley, PH | 1 |
Chapdelaine, JM; Seibold, JR; Whalen, JD; Wooley, PH | 1 |
Fu, KH; Ho, FC | 1 |
Potter, M | 1 |
7 review(s) available for pristane and Disease Models, Animal
Article | Year |
---|---|
Pristane-induced lupus: considerations on this experimental model.
Topics: Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Terpenes | 2017 |
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.
Topics: Animals; Autoantibodies; Disease Models, Animal; Humans; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Signal Transduction; snRNP Core Proteins; Terpenes | 2009 |
Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
Topics: Adjuvants, Immunologic; Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Freund's Adjuvant; Humans; Lupus Erythematosus, Systemic; Mice; Mineral Oil; Squalene; Terpenes; Vaccines | 2004 |
Animal models of rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Animals; Arthritis, Rheumatoid; Collagen; Diamines; Disease Models, Animal; Extracellular Matrix Proteins; Glycoproteins; Matrilin Proteins; Mice; Proteoglycans; Rats; Terpenes | 1999 |
Mouse plasmacytoma: an experimental model of human multiple myeloma.
Topics: Animals; Carcinogens; Disease Models, Animal; Humans; Mice; Multiple Myeloma; Plasmacytoma; Terpenes | 2001 |
The 5TMM series: a useful in vivo mouse model of human multiple myeloma.
Topics: Animals; Cancer Vaccines; Chromosome Aberrations; Disease Models, Animal; Genes, myc; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Multiple Myeloma; Myeloma Proteins; Osteolysis; Paraproteinemias; Peritoneal Neoplasms; Plasmacytoma; Terpenes; Transplantation, Heterologous; Vaccination; Vaccines, DNA | 2000 |
Mediators of joint swelling and damage in rheumatoid arthritis and pristane induced arthritis.
Topics: Animals; Arthritis, Rheumatoid; Disease Models, Animal; Heat-Shock Proteins; Humans; Joints; Mice; Mice, Inbred CBA; T-Lymphocytes; Terpenes | 1992 |
153 other study(ies) available for pristane and Disease Models, Animal
Article | Year |
---|---|
C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
Topics: Adoptive Transfer; Adult; Animals; Apoptosis; Cell Differentiation; Cell Nucleus; Disease Models, Animal; Female; Forkhead Box Protein O1; Gene Expression Regulation; Gene Silencing; Humans; Imiquimod; Lectins, C-Type; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Receptors, Immunologic; Scavenger Receptors, Class E; Syk Kinase; Terpenes | 2021 |
Defective oogenesis in mice with pristane-induced model of systemic lupus.
Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Female; Humans; Lupus Erythematosus, Systemic; Metaphase; Mice; Mice, Inbred BALB C; Oogenesis; Pregnancy; Terpenes | 2021 |
AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation.
Topics: Adenoids; Animals; Antigens, CD19; Cell Differentiation; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Germinal Center; Humans; Immunity, Innate; Lupus Erythematosus, Systemic; Lymph Nodes; Memory B Cells; Mice; Positive Regulatory Domain I-Binding Factor 1; Proto-Oncogene Proteins c-bcl-6; Spleen; Terpenes | 2021 |
TANK prevents IFN-dependent fatal diffuse alveolar hemorrhage by suppressing DNA-cGAS aggregation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Biopsy; Disease Models, Animal; Disease Susceptibility; DNA; Hemorrhage; Immunity, Innate; Immunohistochemistry; Immunosuppressive Agents; Interferons; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Nucleotidyltransferases; Pulmonary Alveoli; Signal Transduction; Terpenes; Toll-Like Receptors | 2022 |
Neutrophils Contribute to ER Stress in Lung Epithelial Cells in the Pristane-Induced Diffuse Alveolar Hemorrhage Mouse Model.
Topics: Animals; Disease Models, Animal; Epithelial Cells; Extracellular Traps; Female; Hemorrhage; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Pulmonary Alveoli; Terpenes | 2022 |
Vitamin D supplementation modulates autophagy in the pristane-induced lupus model.
Topics: Animals; Autophagy; Dietary Supplements; Disease Models, Animal; Lupus Erythematosus, Systemic; Mice; Terpenes; Vitamin D | 2022 |
Pristane attenuates atherosclerosis in Apoe
Topics: Animals; Antibodies, Neutralizing; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Female; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Plasma Cells; RNA | 2022 |
cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus.
Topics: Animals; Autoantibodies; Disease Models, Animal; DNA; Inflammasomes; Inflammation; Lupus Erythematosus, Systemic; Macrophages; Mice; Nucleotidyltransferases | 2022 |
Pristane cadmium chloride nanoemulsion accelerates the onset of systemic lupus erythematosus in a C57BL/6 mouse model.
Topics: Animals; Cadmium Chloride; Disease Models, Animal; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Terpenes | 2023 |
B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Dendritic Cells; Disease Models, Animal; Interleukin-4; Lupus Erythematosus, Systemic; Mice; Monocytes; Neutrophils; Toll-Like Receptor 7 | 2023 |
Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.
Topics: Animals; Autoantibodies; Cytokines; Disease Models, Animal; Humans; Imatinib Mesylate; Interferons; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Molecular Docking Simulation; NF-kappa B | 2023 |
Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Topics: Animals; Disease Models, Animal; Female; Lupus Nephritis; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells; Vasoactive Intestinal Peptide | 2019 |
Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Down-Regulation; Female; Gene Expression; Hippocampus; Lipopolysaccharides; Lupus Erythematosus, Systemic; Maze Learning; Memory Disorders; Memory, Long-Term; Memory, Short-Term; Mice; Mice, Inbred BALB C; Receptors, N-Methyl-D-Aspartate; Terpenes | 2019 |
Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1/Nrf2 activation and suppressing JAK/STAT, NF-κB, MAPK and NLRP3 inflammasome signaling pathways.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Heme Oxygenase-1; Inflammasomes; Iridoid Glucosides; Iridoids; Janus Kinases; Kidney; Lupus Nephritis; MAP Kinase Signaling System; Matrix Metalloproteinase 3; Membrane Proteins; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; STAT Transcription Factors; Terpenes | 2019 |
Combinatorial therapeutic effect of resveratrol and piperine on murine model of systemic lupus erythematosus.
Topics: Alkaloids; Animals; Autoantibodies; Benzodioxoles; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Piperidines; Polyunsaturated Alkamides; Resveratrol; Terpenes; Treatment Outcome | 2020 |
RTD-1 therapeutically normalizes synovial gene signatures in rat autoimmune arthritis and suppresses proinflammatory mediators in RA synovial fibroblasts.
Topics: alpha-Defensins; Animals; Arthritis, Rheumatoid; Cell Line; Cercopithecidae; Cytokines; Disease Models, Animal; Female; Fibroblasts; Humans; Immunosuppressive Agents; Inflammation Mediators; Peptides, Cyclic; Rats; RNA-Seq; Synovial Membrane; Synoviocytes; Terpenes; Transcriptome; Up-Regulation | 2019 |
α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
Topics: Animals; Cell Differentiation; Disease Models, Animal; Female; Immunity, Cellular; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Terpenes; Th17 Cells; Xanthones | 2020 |
Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Cytokines; Disease Models, Animal; Feasibility Studies; Female; Humans; Inflammation; Inflammation Mediators; Lipid Peroxidation; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Oxidative Stress; Reactive Oxygen Species; Terpenes | 2020 |
Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.
Topics: Adolescent; Animals; Disease Models, Animal; Female; Humans; Inflammation; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Progranulins; Terpenes | 2020 |
Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus.
Topics: Animals; beta-Glucans; Cytokines; Dextran Sulfate; Disease Models, Animal; Disease Progression; Feces; Female; Lupus Erythematosus, Systemic; Mice; Receptors, IgG; Terpenes | 2020 |
Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Topics: Animals; Autoantibodies; B-Lymphocytes; Cell Proliferation; Disease Models, Animal; Female; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice, Inbred BALB C; Signal Transduction; Spleen; Sulfonamides; Terpenes; Thiophenes; X-Box Binding Protein 1 | 2020 |
Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
Topics: Animals; Bacterial Translocation; Contraindications, Drug; Dendritic Cells; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Synergism; Dysbiosis; Female; Gastrointestinal Microbiome; Gene Expression Regulation; Glomerulonephritis; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA; RNA-Seq; Specific Pathogen-Free Organisms; Spleen; Terpenes; Tretinoin; Vitamin A | 2020 |
Therapeutic effect of omega-3 fatty acids on T cell-mediated autoimmune diseases.
Topics: Animals; Arthritis, Experimental; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fatty Acids, Omega-3; I-kappa B Kinase; Lymphocyte Activation; MAP Kinase Kinase Kinases; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; T-Lymphocytes; Terpenes | 2020 |
Prophylactic effect of resveratrol and piperine on pristane-induced murine model of lupus-like disease.
Topics: Alkaloids; Animals; Antioxidants; Benzodioxoles; Cytokines; Disease Models, Animal; Female; Inflammation; Kidney; Lipid Peroxidation; Liver; Lung; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Resveratrol; Terpenes | 2020 |
Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis.
Topics: Animals; Chemokine CXCL6; Chronic Disease; Disease Models, Animal; Female; Hemodynamics; Hypoxia; Interleukin-6; Lung; Mice, Inbred C57BL; Phenotype; Pneumonia; Pulmonary Arterial Hypertension; Pulmonary Fibrosis; Severity of Illness Index; Signal Transduction; Terpenes; Up-Regulation | 2020 |
Correlation of the levels of DNA-binding inhibitor Id3 and regulatory T cells with SLE disease severity.
Topics: Animals; Autoantibodies; Case-Control Studies; Disease Models, Animal; Healthy Volunteers; Humans; Inhibitor of Differentiation Protein 1; Inhibitor of Differentiation Proteins; Lupus Erythematosus, Systemic; Mice, Knockout; Mice, Transgenic; Neoplasm Proteins; Severity of Illness Index; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Terpenes; Up-Regulation | 2020 |
A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice.
Topics: Animals; Benzimidazoles; Cell-Free Nucleic Acids; Cytokines; Disease Models, Animal; Female; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Splenomegaly; Terpenes | 2020 |
Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model.
Topics: Animals; Disease Models, Animal; DNA Damage; DNA Glycosylases; Inflammation; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Monocytes; Oxidation-Reduction; Skin; Terpenes | 2020 |
Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models.
Topics: Animals; Autoantibodies; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Hemorrhage; Humans; Immunologic Factors; Injections, Intraperitoneal; Lung; Lupus Nephritis; Mice; Mice, Inbred BALB C; Myxoma virus; Proteinuria; Terpenes; Treatment Outcome; Viral Proteins | 2021 |
Hypertension and endothelial dysfunction in the pristane model of systemic lupus erythematosus.
Topics: Animals; Antibodies, Antinuclear; Arterial Pressure; Autoimmunity; Disease Models, Animal; Endothelium, Vascular; Female; Hypertension; Lupus Erythematosus, Systemic; Mice, Inbred C57BL; Neutrophils; Terpenes; Thymocytes; Vasodilation | 2021 |
Aim2 Couples With Ube2i for Sumoylation-Mediated Repression of Interferon Signatures in Systemic Lupus Erythematosus.
Topics: Animals; Disease Models, Animal; DNA-Binding Proteins; Female; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Sumoylation; Terpenes; Ubiquitin-Conjugating Enzymes | 2021 |
Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Dendritic Cells; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice, Inbred BALB C; Sirolimus; T-Lymphocytes, Helper-Inducer; Terpenes | 2021 |
Pristane-induced mammary carcinomas.
Topics: Animals; Carcinoma; Disease Models, Animal; Mice; Mice, Inbred BALB C; Rats; Terpenes | 2021 |
Erythropoietin Protects against Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization through the EPOR/JAK2/STAT3 Axis.
Topics: Animals; Cell Differentiation; Disease Models, Animal; Erythropoietin; Female; Hemorrhage; Humans; Janus Kinase 2; Lung Diseases; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Pulmonary Alveoli; RAW 264.7 Cells; Receptors, Erythropoietin; Signal Transduction; STAT3 Transcription Factor; Terpenes | 2021 |
Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; Arthritis, Rheumatoid; Chromones; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Humans; Immunoglobulins; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Proteinuria; Sulfonamides; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells | 2021 |
A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis.
Topics: Amino Acid Sequence; Animals; Antigens, Bacterial; Autoantibodies; Autoantigens; Bacteria; Biofilms; Biomarkers; Disease Models, Animal; Disease Progression; Disease Susceptibility; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Transgenic; Peptides; Terpenes | 2021 |
A
Topics: Adenosine; Animals; Autoimmunity; Diabetes Mellitus, Type 1; Disease Models, Animal; Extracellular Traps; Lupus Erythematosus, Systemic; Lymphopenia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Activation; Neutrophils; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Messenger; Signal Transduction; Streptozocin; Terpenes | 2021 |
Dependence on Autophagy for Autoreactive Memory B Cells in the Development of Pristane-Induced Lupus.
Topics: Animals; Autoantibodies; Autoantigens; Autoimmunity; Autophagy; Disease Models, Animal; Lupus Erythematosus, Systemic; Memory B Cells; Mice; Mice, Inbred MRL lpr; Terpenes | 2021 |
Characterization of a PRISTANE-induced lupus-associated model in the non-human primate cynomolgus monkey.
Topics: Animals; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Macaca fascicularis; Terpenes; Ultrasonography | 2018 |
IL‑22 expression is increased variedly in the initial phase, onset and chronic phase of a pristane‑induced arthritis rat model.
Topics: Animals; Arthritis, Experimental; Chronic Disease; Disease Models, Animal; Extremities; Gene Expression Regulation; Interleukin-17; Interleukin-22; Interleukins; Rats; Receptors, Cytokine; RNA, Messenger; Spleen; Synovial Membrane; Terpenes; Transcription Factors | 2017 |
A Novel Subset of Anti-Inflammatory CD138
Topics: Animals; Antigens, Ly; Apoptosis; Bone Marrow Cells; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Humans; Inflammation; Interleukin-10 Receptor alpha Subunit; Lung; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Membrane Proteins; Mice; Mineral Oil; Phagocytosis; Poly I; Receptors, Immunologic; Spleen; Syndecan-1; Terpenes; Tumor Necrosis Factor-alpha | 2017 |
Altered cardiac gene expression of noradrenaline enzymes, transporter and β-adrenoceptors in rat model of rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Blotting, Western; Disease Models, Animal; Gene Expression; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Real-Time Polymerase Chain Reaction; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terpenes; Tyrosine 3-Monooxygenase | 2017 |
Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model.
Topics: Animals; Apoptosis; Autoantibodies; Cytokines; Disease Models, Animal; Female; Fibrosis; Inflammation; Kidney; Kidney Diseases; Kidney Glomerulus; Lupus Nephritis; Melatonin; Mice; Mice, Inbred BALB C; Oxidative Stress; Protective Agents; Terpenes | 2018 |
Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats.
Topics: Animals; Arthritis, Rheumatoid; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Interleukin-22; Interleukins; Lymph Nodes; Rats; Real-Time Polymerase Chain Reaction; Spleen; Terpenes; Th17 Cells | 2017 |
[AMPK over-expression inhibits proliferation, matrix synthesis and inflammation response of glomerular mesangial cells in pristine-induced lupus mice].
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autoantibodies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Extracellular Matrix; Inflammation Mediators; Lupus Erythematosus, Systemic; Male; Mesangial Cells; Mice, Inbred C57BL; Terpenes | 2017 |
Soluble MHC class II-driven therapy for a systemic lupus erythematosus murine experimental in vitro and in vivo model.
Topics: Animals; Antibodies, Antinuclear; Autoantigens; CD4 Antigens; Cells, Cultured; CTLA-4 Antigen; Disease Models, Animal; DNA; Histocompatibility Antigens Class II; Immune Tolerance; Immunosuppression Therapy; Immunotherapy; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes; Terpenes | 2018 |
Liver X Receptor Agonist Therapy Prevents Diffuse Alveolar Hemorrhage in Murine Lupus by Repolarizing Macrophages.
Topics: Animals; Cell Polarity; Disease Models, Animal; Hemorrhage; Humans; Hydrocarbons, Fluorinated; Hypoxia-Inducible Factor 1, alpha Subunit; Liver X Receptors; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Mice; Monocytes; Sulfonamides; Terpenes; Tumor Necrosis Factor-alpha | 2018 |
Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis.
Topics: Acute Kidney Injury; Animals; Antioxidants; Catalase; Cytokines; Disease Models, Animal; Female; Inflammation; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Inbred BALB C; Oxidative Stress; Proteinuria; Quercetin; Superoxide Dismutase-1; Terpenes | 2018 |
Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Topics: Animals; Arthritis; B-Lymphocytes; Disease Models, Animal; Female; Galectins; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Terpenes; Th1 Cells | 2018 |
Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus.
Topics: Animals; Cytokines; Disease Models, Animal; Erythropoietin; Female; Hematopoiesis; Inflammation; Kidney; Lupus Erythematosus, Systemic; Macrophage Activation; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Oligopeptides; Phagocytosis; RAW 264.7 Cells; Terpenes | 2018 |
Effect of active immunization with IL-17A on B cell function and infection risk in pristane-induced lupus model.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antinuclear; Antibodies, Neutralizing; B-Lymphocytes; Disease Models, Animal; Female; Hemocyanins; Immunization; Immunogenicity, Vaccine; Interleukin-17; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Staphylococcal Infections; Terpenes; Time Factors | 2018 |
In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Topics: Animals; Disease Models, Animal; Humans; Immunity, Cellular; Inflammation; Interleukin-10; Interleukin-17; Lactobacillus; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Probiotics; T-Lymphocytes, Regulatory; Terpenes; Th1 Cells; Th17 Cells | 2018 |
IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.
Topics: Adult; Animals; Cell Line; Disease Models, Animal; Epithelium; Female; Gene Expression Regulation; Humans; Interleukin-16; Lung; Lupus Erythematosus, Systemic; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Middle Aged; Neutrophil Infiltration; Neutrophils; Pneumonia; Primary Cell Culture; Terpenes | 2018 |
Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.
Topics: Animals; Blotting, Western; Cell Differentiation; Chemokine CXCL1; Chemokine CXCL2; Disease Models, Animal; Female; Flavonoids; Flavonols; Flow Cytometry; Interleukin-1beta; Interleukin-6; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; RAW 264.7 Cells; Terpenes; Th17 Cells; Tumor Necrosis Factor-alpha | 2018 |
Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Cell Proliferation; Creatinine; Cytokines; Disease Models, Animal; Female; Forkhead Transcription Factors; Granuloma; Kidney Function Tests; Lacticaseibacillus rhamnosus; Lactobacillus delbrueckii; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Probiotics; T-Lymphocytes, Regulatory; Terpenes; Urea | 2019 |
Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Cytokines; Disease Models, Animal; Disease Susceptibility; Female; Humans; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Phagocytosis; Receptors, IgG; Spleen; Terpenes; Th1 Cells | 2019 |
Early Peritoneal CC Chemokine Production Correlates with Divergent Inflammatory Phenotypes and Susceptibility to Experimental Arthritis in Mice.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Chemokines, CC; Cytokines; Disease Models, Animal; Female; Inflammation; Interleukin-6; Male; Mice; Peritoneum; Phenotype; Terpenes | 2019 |
Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model.
Topics: Animals; Arthritis; Cytokines; Disease Models, Animal; Female; Lupus Nephritis; Mice; Mice, Inbred BALB C; Terpenes; Vitamin D | 2019 |
3
Topics: Animals; Antibodies, Antinuclear; Biopsy; Cell Differentiation; Cell Survival; Cell-Free Nucleic Acids; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Inflammation Mediators; Lupus Nephritis; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3; Oleanolic Acid; Terpenes; Th17 Cells; Transcription, Genetic | 2019 |
Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases.
Topics: Animals; Arthritis, Experimental; Autoantibodies; B-Lymphocytes; Collagen; Disease Models, Animal; Germinal Center; Lupus Nephritis; Mice; Receptor for Advanced Glycation End Products; Terpenes | 2019 |
Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Disease Models, Animal; Disease Progression; Female; Granulocytes; Inflammation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Severity of Illness Index; Species Specificity; Terpenes; Time Factors | 2013 |
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Topics: Animals; Apoptosis; BALB 3T3 Cells; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; Flow Cytometry; Immunosuppressive Agents; Kidney Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Reverse Transcriptase Polymerase Chain Reaction; Terpenes; Transcriptome | 2013 |
An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.
Topics: Animals; Autoantibodies; Caspase 1; Cytokines; Disease Models, Animal; Endothelium, Vascular; Glomerulonephritis; Immune Complex Diseases; Immunosuppressive Agents; Inflammasomes; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Terpenes; Vascular Diseases; Vasodilation | 2014 |
Assessment of the translational value of mouse lupus models using clinically relevant biomarkers.
Topics: Animals; Arthritis, Experimental; Autoantibodies; Biomarkers; Disease Models, Animal; Female; Humans; Interferons; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred NZB; Oligonucleotide Array Sequence Analysis; Species Specificity; Terpenes; Translational Research, Biomedical | 2014 |
Induced murine models of systemic lupus erythematosus.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Graft vs Host Disease; Immunoglobulins; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Phenotype; Terpenes | 2014 |
Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Topics: Animals; Autoantibodies; Autoimmunity; Complement C3; Cytokines; Disease Models, Animal; Glomerulonephritis; Humans; Immunity, Humoral; Immunity, Innate; Immunoglobulin G; Interleukin-17; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Knockout; Spleen; Terpenes | 2014 |
Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model.
Topics: alpha-MSH; Animals; Antibodies, Antinuclear; Arthritis; Corticotropin-Releasing Hormone; Cytokines; Disease Models, Animal; Female; Immunoglobulin G; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mice; Nitric Oxide Synthase Type II; Receptor, Melanocortin, Type 1; Terpenes | 2014 |
Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin.
Topics: Acute-Phase Proteins; Animals; Autoantibodies; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunohistochemistry; Interleukin-12; Kidney; Lipocalin-2; Lipocalins; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Proto-Oncogene Proteins; Spleen; Terpenes | 2014 |
Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.
Topics: Animals; Apoptosis; Autoantibodies; Dendritic Cells; Disease Models, Animal; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Neutrophils; Terpenes; Tumor Necrosis Factor-alpha | 2015 |
KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Fibroblasts; Indoles; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Matrix Metalloproteinase 2; Potassium Channel Blockers; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Synovial Membrane; Terpenes | 2015 |
Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.
Topics: Acute Kidney Injury; Animals; Antibodies, Monoclonal; Antigens, CD20; Autoantibodies; B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; Cell Count; Disease Models, Animal; Female; Immunotherapy; Incidence; Interferon-alpha; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Terpenes; Treatment Outcome | 2015 |
No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimicrobial Cationic Peptides; Arthritis, Experimental; Autoantibodies; Blood Cells; Cathelicidins; Chemokines; Cohort Studies; Disease Models, Animal; DNA; Female; Follow-Up Studies; Hemorrhage; Humans; Interferon-alpha; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Mice, Inbred C57BL; Middle Aged; Peritoneal Lavage; RNA; Terpenes; Young Adult | 2014 |
Positional identification of RT1-B (HLA-DQ) as susceptibility locus for autoimmune arthritis.
Topics: Amino Acid Sequence; Amino Acids; Animals; Antibodies, Blocking; Arthritis, Experimental; Arthritis, Rheumatoid; Binding Sites; Body Weight; Disease Models, Animal; Genetic Predisposition to Disease; Genotype; Haplotypes; Histocompatibility Antigens; Humans; Models, Molecular; Molecular Sequence Data; Polymorphism, Genetic; Protein Structure, Tertiary; Rats; Severity of Illness Index; Terpenes | 2015 |
Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.
Topics: Animals; Apoptosis; Autoimmunity; CD4-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Female; Injections, Intraperitoneal; Kidney Glomerulus; Lupus Nephritis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Peritoneum; Peroxidase; Terpenes | 2015 |
Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; B7-1 Antigen; CD28 Antigens; Cell Line; Disease Models, Animal; Female; Genetic Vectors; HEK293 Cells; Humans; Interferon-gamma; Interleukin-4; K562 Cells; Kidney; Lentivirus; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; RNA Interference; Signal Transduction; Spleen; Terpenes | 2015 |
Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Caspase 1; Cells, Cultured; Disease Models, Animal; Ficoll; Genetic Predisposition to Disease; Imidazoles; Immunization; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Knockout; Nitrophenols; Ovalbumin; Phenotype; Phenylacetates; Spleen; T-Lymphocytes; Terpenes; Time Factors | 2016 |
Increased NHC Cells in the Peritoneal Cavity of Plasmacytoma Susceptible BALB/c Mouse.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Inflammation; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oils; Peritoneal Cavity; Plasmacytoma; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells | 2015 |
In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage.
Topics: Animals; Disease Models, Animal; Gene Expression Regulation; Hemorrhage; Immunosuppressive Agents; Lung; Lung Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; NF-kappa B; Oligonucleotides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Terpenes | 2016 |
Differential development of oil granulomas induced by pristane injection in galectin-3 deficient mice.
Topics: Animals; Cytokines; Disease Models, Animal; Extracellular Matrix; Galectin 3; Granulocytes; Granuloma; Inflammation Mediators; Injections; Lymphocyte Subsets; Macrophages, Peritoneal; Mice; Mice, Knockout; Mineral Oil; Terpenes | 2015 |
Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
Topics: Adoptive Transfer; Animals; Antibodies; Antigens, Ly; CD11b Antigen; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Communication; Cell Proliferation; Dinoprostone; Disease Models, Animal; Female; Hemocyanins; Immunization; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Monocytes; Nitric Oxide; Spleen; Terpenes | 2016 |
Maintenance of autoantibody production in pristane-induced murine lupus.
Topics: Animals; Autoantibodies; Autoantigens; B-Lymphocyte Subsets; B-Lymphocytes; Cell Differentiation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunologic Memory; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Plasma Cells; snRNP Core Proteins; Terpenes; Toll-Like Receptor 7 | 2015 |
C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus.
Topics: Animals; Arthritis; Autoantibodies; Chemokines; Complement C1q; Cytokines; Disease Models, Animal; Interferon Inducers; Interferon-alpha; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophages, Peritoneal; Mice, Inbred BALB C; Monocytes; Poly I-C; Terpenes; Toll-Like Receptor 7 | 2016 |
Btk inhibition treats TLR7/IFN driven murine lupus.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Arthritis; Autoantibodies; Disease Models, Animal; Female; Foot Joints; Humans; Immunosuppressive Agents; Interferon Type I; Kidney; Lupus Erythematosus, Systemic; Macrophages; Male; Mice, Inbred C57BL; Mice, Inbred DBA; Nephritis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proteinuria; Terpenes; Toll-Like Receptor 7 | 2016 |
The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Chemokines; Disease Models, Animal; Female; Hepatitis B; Incidence; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Random Allocation; Terpenes | 2016 |
Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Female; Immunosuppressive Agents; Male; Rats; Terpenes | 2016 |
A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
Topics: Adult; Animals; Apoptosis; Autoantibodies; Case-Control Studies; CD18 Antigens; Complement C3; Complement C4; Complement Inactivating Agents; Complement System Proteins; Cytokines; Disease Models, Animal; Elapid Venoms; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Interferon Type I; Lupus Erythematosus, Systemic; Male; Middle Aged; Opsonin Proteins; Phagocytosis; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Terpenes | 2016 |
TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.
Topics: Animals; Cell Lineage; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Flow Cytometry; Immunosuppressive Agents; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Knockout; Myeloid Cells; Polymerase Chain Reaction; Terpenes; Toll-Like Receptor 9 | 2016 |
Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.
Topics: Animals; Antibodies, Antinuclear; Brain; Disease Models, Animal; Female; Infarction, Middle Cerebral Artery; Inflammation Mediators; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Specific Pathogen-Free Organisms; Stroke; Terpenes | 2016 |
"Lupoid hepatitis" in SLE patients and mice with experimental lupus.
Topics: Actins; Adult; Aged; Animals; Autoantibodies; Disease Models, Animal; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Liver; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Muscle, Smooth; Serum Globulins; Terpenes; Young Adult | 2016 |
Establishing a tree shrew model of systemic lupus erythematosus and cell transplantation treatment.
Topics: Animals; Disease Models, Animal; Inflammation; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Terpenes; Tupaiidae; Umbilical Cord | 2016 |
Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.
Topics: Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Humans; Immunity, Innate; Inflammation; Leptin; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; T-Lymphocytes, Regulatory; Terpenes | 2016 |
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
Topics: Animals; Autoantibodies; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Female; Fibrosis; Glomerulonephritis; Humans; Hypergammaglobulinemia; Inflammation; Kidney Tubules; Lupus Nephritis; Membrane Proteins; Mice; Terpenes; Transcription, Genetic; Up-Regulation | 2016 |
Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.
Topics: Animals; Disease Models, Animal; Female; Hemorrhage; Humans; Interleukin-10; Lung; Lung Diseases; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Pulmonary Alveoli; Terpenes | 2017 |
Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Topics: Animals; Annexin A1; Apoptosis; Autoantibodies; Autoantigens; Autoimmunity; B-Lymphocytes; Biomarkers; Cytokines; Disease Management; Disease Models, Animal; Female; Immunization; Immunoglobulin G; Immunophenotyping; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Molecular Targeted Therapy; Spleen; T-Lymphocytes; Terpenes | 2017 |
Aconitine: A potential novel treatment for systemic lupus erythematosus.
Topics: Aconitine; Animals; Antibodies, Antinuclear; Cytokines; Dinoprostone; Disease Models, Animal; Female; Immunoglobulin G; Immunologic Factors; Kidney; Leukocyte Count; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Pilot Projects; Proliferating Cell Nuclear Antigen; Proteinuria; Spleen; Terpenes | 2017 |
Housekeeping gene stability in pristane-induced arthritis and antigen-induced pulmonary inflammation of rats.
Topics: Animals; Arthritis; Disease Models, Animal; Gene Expression; Gene Expression Profiling; Genomic Instability; Immunosuppressive Agents; Inflammation; Lung; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred Strains; Terpenes; Tumor Necrosis Factor-alpha | 2009 |
Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Autoantibodies; B-Lymphocyte Subsets; Crosses, Genetic; Disease Models, Animal; Female; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Count; Lymphocyte Depletion; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Sialic Acid Binding Ig-like Lectin 2; Survival Rate; Terpenes | 2010 |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats.
Topics: Animals; Arthritis, Experimental; Cell Line; Disease Models, Animal; Macrophages; Poly I-C; Rats; Rats, Inbred Strains; RNA Interference; Severity of Illness Index; Spleen; Terpenes; Toll-Like Receptor 3; Toll-Like Receptor 9; Up-Regulation | 2010 |
Distinct granuloma responses in C57BL/6J and BALB/cByJ mice in response to pristane.
Topics: Animals; B-Lymphocytes; Disease Models, Animal; Female; Granuloma; Immunosuppressive Agents; Male; Mesentery; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peritoneum; Phagocytes; Species Specificity; Terpenes | 2010 |
Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.
Topics: Animals; Antibodies, Antinuclear; Cytokines; Disease Models, Animal; Female; Humans; Immunoglobulin M; Immunosuppressive Agents; Interleukin-13; Interleukin-2; Interleukin-6; Kidney; Lupus Erythematosus, Systemic; Male; Melatonin; Mice; Mice, Inbred BALB C; Terpenes | 2010 |
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Topics: Animals; Autoantibodies; Autoimmunity; Cells, Cultured; Cytokines; Disease Models, Animal; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; Mice, Knockout; Terpenes; Th1 Cells; Toll-Like Receptor 4; Toll-Like Receptor 9 | 2010 |
[Study on experimental systemic lupus erythematosus mouse model induced by pristane].
Topics: Animals; Antigen-Antibody Complex; Arthritis; Autoantibodies; B-Lymphocytes; Disease Models, Animal; Female; Immunoglobulin G; Immunosuppressive Agents; Interferon-alpha; Kidney; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Spleen; Terpenes | 2011 |
Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Movement; Cells, Cultured; Culture Media, Conditioned; Disease Models, Animal; Female; Fibroblasts; Gene Expression; Humans; Immunosuppressive Agents; Male; Osteoarthritis; Rats; Rats, Inbred Strains; Severity of Illness Index; Signal Transduction; Synovial Membrane; T-Lymphocytes; Terpenes; Toll-Like Receptor 3; Up-Regulation | 2011 |
Protective effect of pristane on experimental autoimmune uveitis.
Topics: Acetylcysteine; Animals; Autoimmunity; Cell Line; Disease Models, Animal; Eye; Eye Proteins; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Immunization; Immunoglobulin G; Interleukin-17; Mice; Mice, Inbred C57BL; Oxidative Stress; Peptide Fragments; Phytol; Retinol-Binding Proteins; Terpenes; Uveitis | 2011 |
Therapeutic effect of Withania somnifera on pristane-induced model of SLE.
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Cytokines; Disease Models, Animal; Female; Indomethacin; Kidney; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Phytotherapy; Plant Extracts; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Terpenes; Withania | 2012 |
Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Topics: Animals; Autoantibodies; B-Lymphocytes; Carcinogens; Cell Differentiation; Cell Movement; Cytokines; Dendritic Cells; Disease Models, Animal; Humans; Interferon Regulatory Factors; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; T-Lymphocyte Subsets; Terpenes; Th1-Th2 Balance | 2012 |
Bile salt-stimulated lipase plays an unexpected role in arthritis development in rodents.
Topics: Animals; Antibodies, Neutralizing; Arthritis, Experimental; Cartilage; Disease Models, Animal; Female; Gene Dosage; Heterozygote; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Rats; Sterol Esterase; Terpenes | 2012 |
Modulation of multiple experimental arthritis models by collagen-induced arthritis quantitative trait loci isolated in congenic rat lines: different effects of non-major histocompatibility complex quantitative trait loci in males and females.
Topics: Animals; Animals, Congenic; Antigenic Modulation; Arthritis, Experimental; Collagen; Disease Models, Animal; Female; Freund's Adjuvant; Major Histocompatibility Complex; Male; Quantitative Trait, Heritable; Rats; Rats, Inbred F344; Sex Factors; Terpenes; Time Factors | 2002 |
Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis.
Topics: Adjuvants, Immunologic; Animals; Antigens, CD1; Antigens, CD1d; Autoantibodies; B-Lymphocyte Subsets; Cells, Cultured; Coculture Techniques; Cytokines; Disease Models, Animal; Down-Regulation; Galactosylceramides; Gene Deletion; Injections, Intraperitoneal; Killer Cells, Natural; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Species Specificity; T-Lymphocyte Subsets; T-Lymphocytes; Terpenes | 2003 |
A comparative genetic analysis between collagen-induced arthritis and pristane-induced arthritis.
Topics: Animals; Animals, Congenic; Arthritis, Experimental; Chondrosarcoma; Chromosomes, Mammalian; Collagen Type II; Disease Models, Animal; Female; Genetic Linkage; Genotype; Immunosuppressive Agents; Male; Rats; Rats, Inbred Strains; Terpenes; Tumor Cells, Cultured | 2003 |
X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Topics: Agammaglobulinemia; Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Cytokines; DEAD-box RNA Helicases; Disease Models, Animal; DNA, Single-Stranded; Enzyme-Linked Immunosorbent Assay; Genetic Diseases, X-Linked; Immunoglobulin G; Immunosuppressive Agents; Injections, Intraperitoneal; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred CBA; Neoplasm Proteins; RNA Helicases; Terpenes | 2003 |
Two-loci interaction confirms arthritis-regulating quantitative trait locus on rat chromosome 6.
Topics: Animals; Arthritis, Rheumatoid; Chromosome Mapping; Chromosomes, Human, Pair 14; Chromosomes, Mammalian; Disease Models, Animal; Epistasis, Genetic; Humans; Microsatellite Repeats; Models, Genetic; Quantitative Trait Loci; Rats; Synteny; Terpenes | 2003 |
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats.
Topics: Animals; Arthritis; Autoimmune Diseases; B-Lymphocytes; Cell Count; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Profiling; Genetic Predisposition to Disease; Immunity, Innate; Killer Cells, Natural; Lymph Nodes; Lymphocyte Subsets; Male; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Protein Biosynthesis; Proteins; Quantitative Trait Loci; Rats; Rats, Inbred Strains; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Reproducibility of Results; RNA, Messenger; Subtraction Technique; T-Lymphocyte Subsets; Terpenes | 2003 |
Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production.
Topics: Animals; Arthritis; Cells, Cultured; Cyclooxygenase 2; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunosuppressive Agents; Interleukin-6; Isoenzymes; Joints; Macrophages, Peritoneal; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Reverse Transcriptase Polymerase Chain Reaction; Synovial Membrane; Terpenes; Thioglycolates; Tumor Necrosis Factor-alpha; Up-Regulation | 2004 |
Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Chronic Disease; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Interleukin-1; Interleukin-6; Joints; Male; Methotrexate; Mice; Mice, Inbred DBA; p38 Mitogen-Activated Protein Kinases; Prednisolone; Terpenes; Tumor Necrosis Factor-alpha | 2004 |
Murine lupus induced by tetramethylpentadecane: an animal model of systemic human autoimmunity.
Topics: Animals; Disease Models, Animal; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Specific Pathogen-Free Organisms; Terpenes | 2005 |
Pristane-induced autoimmunity in germ-free mice.
Topics: Animals; Autoantibodies; Body Weight; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Granuloma; Histocytochemistry; Hypergammaglobulinemia; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Organ Size; Specific Pathogen-Free Organisms; Spleen; Statistics, Nonparametric; Terpenes | 2005 |
The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice.
Topics: Animals; Disease Models, Animal; Galactosylceramides; Immunosuppressive Agents; Killer Cells, Natural; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Terpenes | 2005 |
Hypercatabolism of IgG in mice with lupus-like syndrome.
Topics: Animals; Base Sequence; Chickens; Disease Models, Animal; DNA, Complementary; Female; Gene Expression; Half-Life; Histocompatibility Antigens Class I; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulins; Iodine Radioisotopes; Kinetics; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Receptors, Fc; Terpenes | 2005 |
Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat.
Topics: Adjuvants, Immunologic; Adoptive Transfer; Animals; Animals, Congenic; Arthritis, Experimental; CD4-Positive T-Lymphocytes; Disease Models, Animal; Female; Histocompatibility Antigens Class II; Interferon-gamma; Lymphocyte Activation; Male; Rats; Rats, Inbred Strains; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocyte Subsets; Terpenes; Tumor Necrosis Factor-alpha | 2006 |
Dissection of the genetic complexity of arthritis using animal models.
Topics: Animals; Arthritis, Experimental; Cartilage; Collagen Type II; Disease Models, Animal; Major Histocompatibility Complex; Mice; NADPH Oxidases; Rats; Terpenes | 2006 |
Involvement of antibody production quantitative trait loci in the susceptibility to pristane-induced arthritis in the mouse.
Topics: Animals; Arthritis, Experimental; Autoantibodies; Crosses, Genetic; Disease Models, Animal; Female; Genetic Predisposition to Disease; Male; Mice; Mice, Inbred Strains; Microsatellite Repeats; Quantitative Trait Loci; Terpenes | 2006 |
Murine model for mantle cell lymphoma.
Topics: Age Factors; Animals; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Flow Cytometry; Genetic Predisposition to Disease; Injections, Intraperitoneal; Lymphoma, Mantle-Cell; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Pilot Projects; Sensitivity and Specificity; Terpenes | 2006 |
[Experimental study of pristane-induced murine lupus model].
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Disease Models, Animal; Female; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Terpenes | 2006 |
Endotoxin induces late increase in the production of pulmonary proinflammatory cytokines in murine lupus-like pristane-primed model [corrected].
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cells, Cultured; Cytokines; Disease Models, Animal; Endotoxins; Female; Interleukin-10; Interleukin-6; Lipopolysaccharides; Lung; Lupus Erythematosus, Systemic; Mice; Mice, Inbred ICR; Terpenes; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Slc11a1 (formerly NRAMP1) gene modulates both acute inflammatory reactions and pristane-induced arthritis in mice.
Topics: Alleles; Animals; Arthritis, Rheumatoid; Cation Transport Proteins; Chromosomes, Mammalian; Cytokines; Disease Models, Animal; Female; Gene Frequency; Genetic Predisposition to Disease; Inflammation; Male; Mice; Mice, Inbred Strains; Microsatellite Repeats; Quantitative Trait Loci; Spleen; Terpenes | 2007 |
Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
Topics: Animals; B-Lymphocytes; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes; Terpenes; Thymus Gland | 2007 |
Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Granuloma, Foreign-Body; Hemorrhage; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Lung; Lung Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Terpenes; Vasculitis | 2007 |
Deficiency of the type I interferon receptor protects mice from experimental lupus.
Topics: Animals; Autoantibodies; Disease Models, Animal; Female; Gene Expression; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoid Tissue; Male; Mice; Mice, Mutant Strains; Receptor, Interferon alpha-beta; Terpenes | 2007 |
The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Autoimmunity; B-Lymphocytes; Disease Models, Animal; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Immunoglobulin G; Immunoglobulin M; Interferon-gamma; Lymph Nodes; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; T-Lymphocytes; Terpenes | 2007 |
Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies.
Topics: Animals; Antibodies, Antinuclear; Apoptosis; Autoimmune Diseases; Cells, Cultured; Chromatin; Deoxyribonucleases; Disease Models, Animal; DNA Fragmentation; Gamma Rays; Immunoglobulin G; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipids; Terpenes | 2007 |
Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Topics: Animals; Autoantibodies; Disease Models, Animal; Female; Lupus Nephritis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ribonucleoproteins, Small Nuclear; Terpenes; Toll-Like Receptor 7 | 2008 |
Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Concanavalin A; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Female; Indomethacin; Inflammation Mediators; Interferon-gamma; Interleukin-10; Interleukin-6; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocytes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Spleen; Terpenes; Thymus Gland; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
Topics: Animals; Antibodies, Antinuclear; Autoantigens; Disease Models, Animal; DNA, Single-Stranded; Female; Glomerulonephritis; Histones; Immune Complex Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Proteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; Terpenes | 1995 |
Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
Topics: Animals; B-Lymphocytes; Bone Marrow; Disease Models, Animal; Hematopoietic Stem Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Plasmacytoma; Species Specificity; Spleen; Terpenes | 1995 |
Contribution of host-derived growth factors to in vivo growth of a transplantable murine mammary carcinoma.
Topics: Animals; Carcinogens; Cell Division; Disease Models, Animal; Epidermal Growth Factor; Immunoglobulin G; Injections, Subcutaneous; Mammary Neoplasms, Experimental; Mice; Peritoneal Cavity; Rabbits; Sheep; Terpenes; Transplantation, Heterologous | 1994 |
Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.
Topics: Animals; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Female; Gene Expression; In Vitro Techniques; Inflammation; Interleukin-6; Isoenzymes; Kinetics; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Peritonitis; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Terpenes | 1996 |
Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Disease Susceptibility; Female; Immunosuppressive Agents; Interleukin-6; Major Histocompatibility Complex; Male; Rats; Rats, Inbred Lew; Species Specificity; T-Lymphocytes; Terpenes | 1996 |
Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.
Topics: Animals; B-Lymphocytes; Cell Transformation, Neoplastic; Disease Models, Animal; Humans; Immunoglobulins; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Multiple Myeloma; Plasmacytoma; Proto-Oncogene Proteins c-myc; Terpenes | 1997 |
Anti-tumour necrosis factor therapy ameliorates joint disease in a chronic model of inflammatory arthritis.
Topics: Animals; Antibodies, Monoclonal; Cricetinae; Disease Models, Animal; Immunoglobulin G; Immunosuppressive Agents; Incidence; Injections, Intraperitoneal; Joint Diseases; Knee Joint; Mice; Mice, Inbred DBA; Severity of Illness Index; Terpenes; Tumor Necrosis Factor-alpha | 1997 |
Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Cytokines; Disease Models, Animal; Female; Hypergammaglobulinemia; Immunoglobulins; Lupus Nephritis; Mice; Mice, Inbred BALB C; Proteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; Specific Pathogen-Free Organisms; Terpenes; Time Factors | 1998 |
Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Female; Glomerulonephritis; Injections, Subcutaneous; Isotonic Solutions; Mice; Mice, Inbred BALB C; Mice, Inbred NZB; Proteinuria; Silicones; Species Specificity; Terpenes | 1998 |
Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats.
Topics: Administration, Intranasal; Animals; Arthritis, Experimental; Collagen; Disease Models, Animal; Immunosuppressive Agents; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Terpenes; Th1 Cells; Vaccination | 1999 |
Immunopathogenesis of environmentally induced lupus in mice.
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Environmental Exposure; Female; Glomerulonephritis; Granuloma; Humans; Lupus Erythematosus, Systemic; Mercuric Chloride; Mice; Mice, Inbred BALB C; Terpenes | 1999 |
B cell subsets in pristane-induced autoimmunity.
Topics: Animals; Autoantibodies; Autoimmune Diseases; B-Lymphocyte Subsets; CD5 Antigens; Cell Lineage; Disease Models, Animal; Female; Genetic Predisposition to Disease; Immunoglobulin D; Immunoglobulin G; Immunoglobulin M; Injections, Intraperitoneal; Interferon-gamma; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Peritoneal Cavity; Specific Pathogen-Free Organisms; Spleen; Terpenes | 2000 |
Amelioration of arthritis in two murine models using antibodies to oncostatin M.
Topics: Animals; Antibodies; Arthritis, Experimental; Bacterial Proteins; Chaperonin 60; Chaperonins; Collagen; Disease Models, Animal; DNA Primers; Edema; Glyceraldehyde-3-Phosphate Dehydrogenases; Immunoglobulin G; Joints; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Oncostatin M; Peptides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terpenes | 2001 |
Genetic links between the acute-phase response and arthritis development in rats.
Topics: Acute Disease; Acute-Phase Proteins; Animals; Arthritis, Rheumatoid; Breeding; Chronic Disease; Disease Models, Animal; Female; Fibrinogen; Genotype; Immunosuppressive Agents; Interleukin-6; Joints; Lod Score; Male; Orosomucoid; Phenotype; Rats; Rats, Inbred Lew; Specific Pathogen-Free Organisms; Terpenes | 2002 |
Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis.
Topics: Animals; Arthritis; Arthritis, Rheumatoid; Disease Models, Animal; Exudates and Transudates; Glycosylation; Immunoglobulin G; Interleukin-6; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Terpenes | 1992 |
Modulation of pristane-induced arthritis by mycobacterial antigens.
Topics: Animals; Antigens, Bacterial; Arthritis; Autoradiography; Carcinogens; Densitometry; Disease Models, Animal; Dose-Response Relationship, Immunologic; Electrophoresis, Polyacrylamide Gel; Freund's Adjuvant; Heat-Shock Proteins; Immunoglobulin G; Immunotherapy; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Inbred CBA; Mycobacterium; Terpenes; Vaccination | 1991 |
Pristane induced arthritis. II. Genetic regulation in F1 hybrid mice and cellular immune abnormalities following pristane injection.
Topics: Animals; Arthritis; Carcinogens; Collagen; Concanavalin A; Disease Models, Animal; Hybridization, Genetic; Hypersensitivity, Delayed; Immune Tolerance; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Terpenes | 1991 |
Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease.
Topics: Animals; Arthritis; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Carcinogens; Disease Models, Animal; Disease Susceptibility; Major Histocompatibility Complex; Mice; Mice, Inbred Strains; Terpenes | 1989 |
A new model of AA-amyloidosis induced by oral pristane in BALB/c mice.
Topics: Administration, Oral; Amyloidosis; Animals; Carcinogens; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Liver; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron; Serum Amyloid A Protein; Spleen; Splenic Diseases; Terpenes; Time Factors | 1987 |
Plasmacytomas in mice.
Topics: Animals; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 8; Disease Models, Animal; Freund's Adjuvant; Humans; Mice; Mice, Inbred Strains; Mineral Oil; Multiple Myeloma; Oncogenes; Plasmacytoma; Rats; Terpenes; Translocation, Genetic | 1986 |